Correlation Between Collins Foods and Invex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collins Foods and Invex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collins Foods and Invex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collins Foods and Invex Therapeutics, you can compare the effects of market volatilities on Collins Foods and Invex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collins Foods with a short position of Invex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collins Foods and Invex Therapeutics.

Diversification Opportunities for Collins Foods and Invex Therapeutics

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Collins and Invex is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Collins Foods and Invex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invex Therapeutics and Collins Foods is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collins Foods are associated (or correlated) with Invex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invex Therapeutics has no effect on the direction of Collins Foods i.e., Collins Foods and Invex Therapeutics go up and down completely randomly.

Pair Corralation between Collins Foods and Invex Therapeutics

Assuming the 90 days trading horizon Collins Foods is expected to generate 0.31 times more return on investment than Invex Therapeutics. However, Collins Foods is 3.26 times less risky than Invex Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Invex Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  667.00  in Collins Foods on September 13, 2024 and sell it today you would earn a total of  120.00  from holding Collins Foods or generate 17.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Collins Foods  vs.  Invex Therapeutics

 Performance 
       Timeline  
Collins Foods 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collins Foods has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Collins Foods is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Invex Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Invex Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental indicators, Invex Therapeutics is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Collins Foods and Invex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collins Foods and Invex Therapeutics

The main advantage of trading using opposite Collins Foods and Invex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collins Foods position performs unexpectedly, Invex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invex Therapeutics will offset losses from the drop in Invex Therapeutics' long position.
The idea behind Collins Foods and Invex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like